Featured Stories
MUST READ:Sy Schlager and Therapeutic Window Sy Schlager Helps People Like Us Things You May Not Know about Sy Schlager
 
MUST READ:Sy Schlager and Therapeutic Window

MUST READ:Sy Schlager and Therapeutic Window

Therapeutic Window is the company that Sy Schlager began, and which he is both President and Chief Medical Officer of. This company is the culmination of many years dedicated research and study by Schlager, in a field where he has always led the way, resulting in many awards and recognition of his talents. Sy Schlager [...]

Sy Schlager Helps People Like Us

Sy Schlager Helps People Like Us

Unless you are involved in the world of medicine, the name Sy Schlager may not mean a great deal to you. In fact, it is quite feasible that you have not heard of him before this moment, so why would anything that he does, or has done be of any help to us? Well, the [...]

Things You May Not Know about Sy Schlager

Things You May Not Know about Sy Schlager

Sy Schlager is a pretty well known name in the world of medicine and research, as well it should be because he has devoted his entire life to the advancement of both, and in making sure that other health professionals, and their patients can benefit and prosper from his tireless energy and work. What is [...]

MUST READ:Sy Schlager and Therapeutic Window

Therapeutic Window is the company that Sy Schlager began, and which he is both President and Chief Medical Officer of. This company is the culmination of many years dedicated research and study by Schlager, in a field where he has always led the way, resulting in many awards and recognition of his talents.

Sy Schlager began his career with an impressive PhD in microbiology-immunology that he got from the University of Illinois Medical Center in Chicago, after which he completed a postdoctoral fellowship at the National Cancer Institute in Bethesda in Maryland. He was recognized as being a Cancer Expert, and moved on from here to become the head of immunology at the University of Notre Dame, where he made his mark with all levels of students from undergraduates to postdoctoral fellows.

Sy Schlager’s next qualification was to become an MD, for which he studied at the University of Miami, followed by an internship and residency back in Chicago. After a few years in his own private practice specializing in internal medicine, Sy Schlager moved to Abbott Laboratories as the leader of a program that researched AIDS and antiviral treatments. After a while, he was a founding member in creating Academic Pharmaceuticals.

Sy Schlager’s energy knows no bounds and he has also managed to graduate from the Witkin School of Law cum laude. Throughout this remarkable career, Sy Schlager managed to pick up a stream of awards and accolades for his services to medicine and research, and it is this vast knowledge that he brings to his current venture, Therapeutic Window.

Therapeutic Window is responsible for teaching those who are already qualified in the medical profession. It is a legal requirement that medical professionals keep their knowledge updated if they wish to retain certification and licensure, but often the demands on their time make this difficult.

Sy Schlager, and his team, make sure that they have access to the resources that they need to keep themselves updated on any breakthroughs or new innovations that is relevant to their particular field. These educational resources are prepared in a wide range of media so that they suit all learning styles and cover a vast range of subjects.

Sy Schlager is dedicated to improving the medical profession, and in turn, patient experience, and his input and knowledge are phenomenal. Luckily, for all concerned, he is happy to share it.

About Sy

Sy Schlager, and his team, make sure that they have access to the resources that they need to keep themselves updated on any breakthroughs or new innovations that is relevant to their particular field. These educational resources are prepared in a wide range of media so that they suit all learning styles and cover a vast range of subjects.